Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 12, 2024Sri Lanka Journal of Diabetes Endocrinology and MetabolismOpen Access

Etomidate in the Treatment of Severe Cushing Syndrome: The Sri Lankan Experience

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDimutha MuthukudaKJKushalee Poornima JayawickremeKLK. Liyanarachchi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Muthukuda et al. (2024) studied this question.

synapsesocial.com/papers/68e58ba1b6db643587527392https://doi.org/10.4038/sjdem.v15i2.7524
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 18281 Continuous Low-Dose Etomidate Infusion For The Management Of Severe Hypercortisolism In Metastatic Adrenocortical Carcinoma2024
  2. 2212: ETOMIDATE, KETOCONAZOLE, AND MITOTANE FOR CUSHING DISEASE DUE TO ADRENOCORTICAL CARCINOMA2026
  3. 3Etomidate Monotherapy for Perioperative Control of Hypercortisolism in a Mitotane-Intolerant Patient With Adrenocortical Carcinoma: A Case Report2026
  4. 4A52-05 Use of Etomidate to Reduce Pressor Requirements in a Patient With Severe Ectopic Acth Syndrome Presenting With Shock2026
  5. 5Normalization of Potassium Despite 11-Deoxycorticosterone Rise During Etomidate Therapy in Adrenocortical Carcinoma2026